QC
LXRX icon

Quadrature Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History

Quadrature Capital’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$172K Buy
110,379
+91,965
+499% +$134K ﹤0.01% 1150
2025
Q4 		$21.2K Sell
18,414
-209,795
-92% -$288K ﹤0.01% 1206
2025
Q3 		$309K Buy
+228,209
New +$259K ﹤0.01% 660

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Quadrature Capital's LXRX Position: Q1 2026 in Review

Quadrature Capital increased its Lexicon Pharmaceuticals (LXRX) stake by 499% in Q1 2026, buying an estimated $134K and bringing the position to 110,379 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #1150.

Quadrature Capital first reported a position in LXRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $309K in Q3 2025. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Quadrature Capital held 110,379 shares of Lexicon Pharmaceuticals worth $172K as of Q1 2026.
  • Quadrature Capital bought 91,965 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $134K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Quadrature Capital's portfolio in Q1 2026, its #1150 holding.
  • Quadrature Capital first reported a position in Lexicon Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Quadrature Capital's Lexicon Pharmaceuticals position peaked at $309K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.